With an 11 billion DKK investment in Hillerød, the global CDMO is pushing the boundaries in fields like fill-finish capacity, while also expanding its engineering, process science, quality, and supply chain management departments. The addition of 8 x 20,000L bioreactors and two downstream processing streams at the Hillerød manufacturing site will make it the largest end-to-end CDMO in Europe and create 450 new jobs.